Harpoon Therapeutics, Inc. Gains 30.63%
Fri, Aug 21, 2020 at 05:34 PM
Harpoon Therapeutics, Inc. (HARP:NASDAQ) soared at $15.31, a gain of 30.6%. On Thu 20 Aug 20, HARP:NASDAQ touched a New 2-Week Intraday Low of $11.34. The stock appeared on our News Catalysts scanner on Wed 05 Aug 20 at 04:14 PM in the 'INVESTOR UPDATE' category. From Thu 06 Aug 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Harpoon Therapeutics, Inc. (HARP:NASDAQ)
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 63.89%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 30.96%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 30.63%
- ShiftPixy, Inc. (PIXY:NASDAQ), 27.03%
- Velocity Financial, Inc. (VEL:NYSE), 24.88%
- Gridsum Holding Inc. (GSUM:NASDAQ), 24.17%
- Moxian, Inc. (MOXC:NASDAQ), 22%
- Midatech Pharma plc (MTP:NASDAQ), 21.9%
- SPAR Group, Inc. (SGRP:NASDAQ), 19.91%
- The Buckle, Inc. (BKE:NYSE), 18.81%